BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10439166)

  • 81. [Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) in the diagnosis and preoperative staging of head and neck tumors: a prospective study].
    Mattei R; Rubello D; Ferlin G; Bagatella F
    Acta Otorhinolaryngol Ital; 1998 Dec; 18(6):387-91. PubMed ID: 10388152
    [TBL] [Abstract][Full Text] [Related]  

  • 82. FDG PET evaluation of head and neck cancer: value of imaging the thorax.
    Keyes JW; Chen MY; Watson NE; Greven KM; McGuirt WF; Williams DW
    Head Neck; 2000 Mar; 22(2):105-10. PubMed ID: 10679897
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor].
    Fakhry N; Jacob T; Paris J; Barberet M; Mundler O; Giovanni A; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 2006 Feb; 123(1):17-25. PubMed ID: 16609665
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
    Schechter NR; Gillenwater AM; Byers RM; Garden AS; Morrison WH; Nguyen LN; Podoloff DA; Ang KK
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):4-9. PubMed ID: 11516844
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detection of unknown occult primary tumors using positron emission tomography.
    Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
    Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
    Shinohara M; Tomita M; Ohira S; Nishimura A
    Hokkaido Igaku Zasshi; 1999 May; 74(3):249-56. PubMed ID: 10422568
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Positron emission tomographic imaging of head and neck lesions.
    Sakamoto H; Nakai Y; Ohashi Y; Okamura T; Ochi H
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S123-6. PubMed ID: 9065645
    [TBL] [Abstract][Full Text] [Related]  

  • 88. FDG-PET/CT of head and neck squamous cell carcinoma in a rat model.
    Aubry K; Shao Z; Monteil J; Paraf F; Bessède JP; Rigaud M
    Mol Imaging Biol; 2009; 11(2):88-93. PubMed ID: 19034583
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PET scanning in head and neck oncology: a review.
    McGuirt WF; Greven K; Williams D; Keyes JW; Watson N; Cappellari JO; Geisinger KR
    Head Neck; 1998 May; 20(3):208-15. PubMed ID: 9570626
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The role of FDG PET in the clinical management of head and neck cancer.
    Stokkel MP; ten Broek FW; van Rijk PP
    Oral Oncol; 1998 Nov; 34(6):466-71. PubMed ID: 9930356
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?
    Silva P; Hulse P; Sykes AJ; Carrington B; Julyan PJ; Homer JJ; Hastings DL; Slevin NJ
    J Laryngol Otol; 2007 Feb; 121(2):149-53. PubMed ID: 17059628
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy.
    Berlangieri SU; Brizel DM; Scher RL; Schifter T; Hawk TC; Hamblen S; Coleman RE; Hoffman JM
    Head Neck; 1994; 16(4):340-6. PubMed ID: 8056579
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Positron emission tomography in the early follow-up of advanced head and neck cancer.
    Goerres GW; Schmid DT; Bandhauer F; Huguenin PU; von Schulthess GK; Schmid S; Stoeckli SJ
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):105-9; discussion 120-1. PubMed ID: 14732778
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation.
    Meyer MA; Nathan CO
    Clin Nucl Med; 2000 Apr; 25(4):279-80. PubMed ID: 10750967
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
    Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
    Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
    [TBL] [Abstract][Full Text] [Related]  

  • 96. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
    Hirshoren N; Olayos E; Callahan J; Lau E
    Laryngoscope; 2016 Nov; 126(11):2480-2483. PubMed ID: 27114188
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392).
    Gregoire V; Daisne JF; Geets X
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):308-9; author reply 309. PubMed ID: 16111601
    [No Abstract]   [Full Text] [Related]  

  • 98. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?
    Pellitteri PK; Ferlito A; Rinaldo A; Shah JP; Weber RS; Lowry J; Medina JE; Gourin CG; Robbins KT; Suárez C; Shaha AR; Genden EM; Leemans CR; Lefebvre JL; Kowalski LP; Wei WI
    Head Neck; 2006 Feb; 28(2):166-75. PubMed ID: 16240327
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients.
    Cho SB; Chung WG; Yun M; Lee JD; Lee MG; Chung KY
    Dermatol Surg; 2005 Apr; 31(4):442-6; discussion 446-7. PubMed ID: 15871320
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diagnostic utility of positron emission tomography-computed tomography for predicting malignancy in cystic neck masses in adults.
    Ferris RL; Branstetter BF; Nayak JV
    Laryngoscope; 2005 Nov; 115(11):1979-82. PubMed ID: 16319609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.